Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-22,385
Closed -$905K 4560
2017
Q4
$957K Buy
+22,385
New +$893K ﹤0.01% 1957
2017
Q3
Sell
-18,213
Closed -$735K 4669
2017
Q2
$827K Sell
18,213
-2,831
-13% -$125K ﹤0.01% 2085
2017
Q1
$895K Buy
+21,044
New +$858K 0.01% 1778
2016
Q1
Sell
-106,542
Closed -$3.72M 4653
2015
Q4
$4.12M Sell
106,542
-407,995
-79% -$15.9M 0.03% 849
2015
Q3
$20.1M Buy
514,537
+54,498
+12% +$2.16M 0.11% 224
2015
Q2
$17.5M Sell
460,039
-16,567
-3% -$580K 0.1% 219
2015
Q1
$15.7M Buy
476,606
+246,863
+107% +$7.58M 0.12% 174
2014
Q4
$6.14M Buy
229,743
+124,976
+119% +$3.23M 0.05% 546
2014
Q3
$2.55M Buy
104,767
+75,889
+263% +$1.92M 0.02% 1059
2014
Q2
$732K Buy
+28,878
New +$675K 0.01% 1940
2014
Q1
Sell
-1,636
Closed -$37K 5100
2013
Q4
$37K Buy
+1,636
New +$36.1K ﹤0.01% 4430
2013
Q3
Sell
-53,300
Closed -$1.03K 5258
2013
Q2
$1.03K Buy
+53,300
New +$1.11M ﹤0.01% 2108

Other funds holding HOLX

PEAK6 Group's HOLX Position: Q1 2018 in Review

PEAK6 Group sold out of Hologic (HOLX) in Q1 2018, closing a stake of 22,385 shares — an estimated $905K sold.

PEAK6 Group first reported a position in HOLX in Q2 2013 and held it in 12 quarters. The position peaked at $20.1M in Q3 2015. 462 funds tracked by Wall St. Rank hold HOLX as of Q1 2018.

  • PEAK6 Group reported no remaining Hologic position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 22,385 Hologic shares in Q1 2018, an estimated $905K.
  • PEAK6 Group first reported a position in Hologic in Q2 2013 and held it in 12 quarters.
  • PEAK6 Group's Hologic position peaked at $20.1M in Q3 2015.
  • 462 funds tracked by Wall St. Rank held Hologic as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.